drugset / Trial / NCT02904213
Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks
Completed
330 enrolled
Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
Biological E. Limited · collab
NaSingle-groupOpen-labelPrevention
Summary
An open label, non-comparative bridging study to evaluate the safety of pentavalent vaccine ComBe Five (Liquid) made in India, in healthy Vietnamese children aged from 8 - 10 weeks as a 3-dose series, interval for each dose is 4 weeks
Timeline
- Start
- 2016-09-16
- Primary completion
- 2016-12-19
- Completion
- 2017-06-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ComBe Five | Vaccine | 0.5 ml | — |
Indications
No indication recorded.